The iovera° system is intended to temporarily block pain at peripheral nerve sites. The treatment effect is immediate and lasts until the nerve has regenerated. I n a single-arm, post-market clinical study of knee pain, 70% of patients reported an effect 56 days post-treatment. Common side effects include local pain, tenderness, swelling, bruising and tingling or numbness. Typically these reactions resolve with no physician intervention.